Investor Relations

VBL Therapeutics (Nasdaq: VBLT) is seeking to improve care for cancer and immune-inflammatory diseases by inventing targeted medicines with the potential for broad impact. For additional information and catalysts, see our corporate presentation.

Corporate Presentation

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart